Sanders wants to replace patents with prizes for drug inventions
SenatehealthcommitteeChairBernieSanders(I-Vt.)wantstorewardnewmedicineswithprizemoney.JoseLuisMagana
-
Malaria cases in Florida and Texas: Here’s what you need to know
-
How the Dana
-
What does generative AI mean for health care? We asked experts
-
Dementia risk linked to living in disadvantaged areas: Study
-
Trump demands the U.S. pay no more for drugs than other countries … again
-
Are infertility treatments 'essential' during the Covid
How the Dana
ThecorporateofficesofMassachusettsGeneralBrighamhospitalsinAssemblySquareinSomerville.LaneTurner/Glo
Medical leaders decry Supreme Court decision on affirmative action
- Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
- STAT Virtual Event: How to Increase Diversity in Clinical Trials
- How one medical school became remarkably diverse
- The stock market has soared this year, but will it last? Experts weigh in
- In Memoriam: Notable people who died in 2023
- A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year
- Activists slam private health insurers over coverage restrictions
- Telehealth startups are trying to fill the menopause care vacuum
- Hollywood unions extend contract negotiations for actors
- Researchers use wearables data and AI to predict preterm birth risk
- Trump demands the U.S. pay no more for drugs than other countries … again
- Data show record exodus of life scientists from academia
- Guidelines to prevent youth baseball injuries need more muscle
- Ionis has late
- Psychedelics group wrestles with new pharma identity
- FDA advisers vote against ALS treatment from BrainStorm
- Anesthesiologist group: stop taking Ozempic before surgery
- Shingles, which affected Dianne Feinstein, is on the rise
- BioMarin wins approval for gene therapy to treat hemophilia A
- Mystery swirls around US soldier who entered North Korea days ago, officials say
- Activists slam private health insurers over coverage restrictions
- The stock market has soared this year, but will it last? Experts weigh in
- Moonlake's readout produced a cash windfall. Risks remain
- Scientists grapple with ethics of stem cell research
- 23andMe had bad news about my health. I wish a person had delivered it
- A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year
- New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
- Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal
- Medicare details structure of new drug price negotiation program
- FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi
- Heart attack and stroke risk calculators need revising
- How a Boston hospital is priming medical residents to use GPT
- 5 dead in mass shooting on Caribbean island of St. Vincent: Police
- There’s a way to spot data fakery. All journals should be using it
- 'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more
- Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal
- Ionis has late
- Stanford president’s abrupt resignation sparks debate
- A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year
- Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal
'CMA Fest' 2023: How to watch, who is performing and more
- US jobless claims fall again as labor market continues to flash strength
- Judge denies Trump's request for new trial in E. Jean Carroll case
- Listen: Who gets the credit for GLP
- How a Boston hospital is priming medical residents to use GPT
- US jobless claims fall again as labor market continues to flash strength
- Address the ethical violations that led to 'Three Identical Strangers'
- Why do women spend more than men on medical expenses?
- The stock market has soared this year, but will it last? Experts weigh in
- US jobless claims fall again as labor market continues to flash strength
- Medicaid, Medicare dual
- Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024
- Menendez indictment could see pharma lose a key ally
- Shingles, which affected Dianne Feinstein, is on the rise
- Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024
- Scientists grapple with ethics of stem cell research
- In rare move, senator releases unverified FBI source report alleging Biden bribe
- FDA seeks to regulate lab
- Telehealth startups are trying to fill the menopause care vacuum
- Cigna to pay $172 million to settle Medicare Advantage fraud probe
- Why do women spend more than men on medical expenses?
- Ionis has late
- Are infertility treatments 'essential' during the Covid
- Inequities make cancer less preventable for women: report
- 'CMA Fest' 2023: How to watch, who is performing and more
- How one patient went off dialysis — and others can too
- 'CMA Fest' 2023: How to watch, who is performing and more
- A new ‘biological computer' targets cancer while sparing healthy cells
- Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services
- Would Medicare drug price negotiations stall in a shutdown?
- Biogen shutters digital health group, ends Apple study, in cost cutting move
- How the Dana
- How one patient went off dialysis — and others can too
- Health tech startups drop sharply from 2021 highs
- Caribou posts encouraging results on off
- After a drawn out lobbying fight, ARPA
- Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off
- Judge denies Trump's request for new trial in E. Jean Carroll case
- 'CMA Fest' 2023: How to watch, who is performing and more
- Medicaid, Medicare dual
- How a Boston hospital is priming medical residents to use GPT